Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway
2018 · Journal of Experimental & Clinical Cancer Research · 77 citations
https://doi.org/10.1186/s13046-018-0718-2
X
Xiang Hu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
95
Papers
2.0K
Citations
24
h-index
35
i10-index
Xiang Hu is an academic researcher from Wenzhou Medical University. The author has contributed to research in topics: Gastric Cancer Management and Outcomes & Metastasis and carcinoma case studies & Cancer Cells and Metastasis. The author has an h-index of 24, co-authored 81 publications.
ORCID: 0000-0003-1536-0036Papers by this author
worksAdjuvant chemotherapy for rectal cancer with complete pathological response (pCR) may not be necessary: a pooled analysis of 5491 patients
2019 · Cancer Cell International · 19 citations
https://doi.org/10.1186/s12935-019-0851-9
Personalized circulating tumor DNA monitoring improves recurrence surveillance and management after curative resection of colorectal liver metastases: a prospective cohort study
2024 · International Journal of Surgery · 17 citations
https://doi.org/10.1097/js9.0000000000001236
Preservation of the celiac branch of the vagus nerve reduces the incidence of postoperative diarrhea in gastric cancer: a cohort study
2024 · World Journal of Surgical Oncology · 1 citations
https://doi.org/10.1186/s12957-024-03370-0
The natural product-derived JM-9 alleviates high-fat diet-induced fatty liver in mice by targeting MD2
2025 · International Immunopharmacology · 0 citations
https://doi.org/10.1016/j.intimp.2025.114053
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat